Boston Partners’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
SBH
RA
Boston Partners's NGVT Position: Q2 2026 in Review
Boston Partners increased its Ingevity (NGVT) stake by 2.5% in Q2 2026, buying an estimated $697K and bringing the position to 389,683 shares worth $29.1M. The position accounts for 0.03% of the portfolio, ranked #342.
Boston Partners first reported a position in NGVT in Q1 2020 and has held it in 19 quarters since. The position peaked at $189M in Q2 2021. 315 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.
- Boston Partners held 389,683 shares of Ingevity worth $29.1M as of Q2 2026.
- Boston Partners bought 9,684 Ingevity shares in Q2 2026, an estimated $697K.
- Ingevity made up 0.03% of Boston Partners's portfolio in Q2 2026, its #342 holding.
- Boston Partners first reported a position in Ingevity in Q1 2020 and has held it in 19 quarters since.
- Boston Partners's Ingevity position peaked at $189M in Q2 2021.
- 315 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.
Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.